Literature DB >> 9322071

A study of photobactericidal activity in the phenothiazinium series.

M Wainwright1, D A Phoenix, J Marland, D R Wareing, F J Bolton.   

Abstract

The photodynamic antibacterial properties of a closely related series of commercially available phenothiazinium dyes were tested against a range of pathogenic strains of Gram-positive (Staphylococcus aureus, Enterococcus faecalis, Bacillus cereus) and Gram-negative organisms (Escherichia coli, Pseudomonas aeruginosa). The photosensitisers were illuminated using a non-laser light source at a fluence of 1.75 mW cm-2 and this resulted in the enhancement of antibacterial activity in liquid culture. In several cases, illumination resulted in considerable decreases in the minimum lethal concentrations required, giving up to 100-fold increases in bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9322071     DOI: 10.1111/j.1574-695X.1997.tb01074.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  30 in total

1.  Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice.

Authors:  Tianhong Dai; Vida J Bil de Arce; George P Tegos; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps.

Authors:  George P Tegos; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Photodynamic treatment of endodontic polymicrobial infection in vitro.

Authors:  Jacob Lee Fimple; Carla Raquel Fontana; Federico Foschi; Karriann Ruggiero; Xiaoqing Song; Tom C Pagonis; Anne C R Tanner; Ralph Kent; Apostolos G Doukas; Philip P Stashenko; Nikolaos S Soukos
Journal:  J Endod       Date:  2008-04-25       Impact factor: 4.171

4.  Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation.

Authors:  George P Tegos; Kayo Masago; Fatima Aziz; Andrew Higginbotham; Frank R Stermitz; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

5.  The Antibacterial Effect of Additional Photodynamic Therapy in Failed Endodontically Treated Teeth: A Pilot Study.

Authors:  Mohammad Asnaashari; Hamed Homayuni; Payam Paymanpour
Journal:  J Lasers Med Sci       Date:  2016-10-27

Review 6.  Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond.

Authors:  Fatma Vatansever; Wanessa C M A de Melo; Pinar Avci; Daniela Vecchio; Magesh Sadasivam; Asheesh Gupta; Rakkiyappan Chandran; Mahdi Karimi; Nivaldo A Parizotto; Rui Yin; George P Tegos; Michael R Hamblin
Journal:  FEMS Microbiol Rev       Date:  2013-07-25       Impact factor: 16.408

7.  Structure-function relationships of Nile blue (EtNBS) derivatives as antimicrobial photosensitizers.

Authors:  Daniela Vecchio; Brijesh Bhayana; Liyi Huang; Elisa Carrasco; Conor L Evans; Michael R Hamblin
Journal:  Eur J Med Chem       Date:  2014-02-01       Impact factor: 6.514

8.  Antimicrobial mechanisms behind photodynamic effect in the presence of hydrogen peroxide.

Authors:  Aguinaldo Silva Garcez; Silvia Cristina Núñez; Mauricio S Baptista; Nasser Ali Daghastanli; Rosangela Itri; Michael R Hamblin; Martha Simões Ribeiro
Journal:  Photochem Photobiol Sci       Date:  2010-12-02       Impact factor: 3.982

9.  Endodontic photodynamic therapy ex vivo.

Authors:  Raymond Ng; Fiza Singh; Despina A Papamanou; Xiaoqing Song; Chitrang Patel; Colleen Holewa; Niraj Patel; Vanja Klepac-Ceraj; Carla R Fontana; Ralph Kent; Tom C Pagonis; Philip P Stashenko; Nikolaos S Soukos
Journal:  J Endod       Date:  2011-02       Impact factor: 4.171

10.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

Authors:  Sulbha K Sharma; Pawel Mroz; Tianhong Dai; Ying-Ying Huang; Tyler G St Denis; Michael R Hamblin
Journal:  Isr J Chem       Date:  2012-09       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.